LLY earnings & options Eli Lilly and Company
Implied vs actual, past reports
Definitions →Solid bars: the actual two-session reaction around each report (signed value printed below). Amber outlines: the move options priced beforehand — recorded from August 2026 onward, so older reports show the actual only.
Report-by-report record
| Report date | EPS act / est | Revenue act / est | Reaction | Implied | IV30 before → after |
|---|---|---|---|---|---|
| Aug 05, 2026 | 8.38 / 6.40 | 22.97B / 20.82B | +6.8% | not recorded | — |
| Apr 30, 2026 | 8.55 / 6.97 | 19.80B / 17.82B | +13.2% | not recorded | — |
| Feb 04, 2026 | 7.54 / 6.91 | 19.29B / 17.94B | +1.7% | not recorded | — |
| Oct 30, 2025 | 7.02 / 5.69 | 17.60B / 16.05B | +6.1% | not recorded | — |
| Aug 07, 2025 | 6.31 / 5.60 | 15.56B / 14.70B | -16.2% | not recorded | — |
| May 01, 2025 | 3.34 / 3.26 | 12.73B / 12.67B | -8.4% | not recorded | — |
| Feb 06, 2025 | 5.32 / 5.03 | 13.53B / — | +4.3% | not recorded | — |
| Oct 30, 2024 | 1.18 / 1.47 | 11.44B / 12.10B | -8.2% | not recorded | — |
| Aug 08, 2024 | 3.92 / 2.60 | 11.30B / 9.98B | +15.5% | not recorded | — |
| Apr 30, 2024 | 2.58 / 2.46 | 8.77B / 8.94B | +5.4% | not recorded | — |
| Feb 06, 2024 | 2.49 / 2.22 | 9.35B / 8.93B | +2.7% | not recorded | — |
| Nov 02, 2023 | 0.10 / -0.08 | 9.50B / 8.95B | +2.4% | not recorded | — |
| Aug 08, 2023 | 2.11 / 1.98 | 8.31B / 7.58B | +15.9% | not recorded | — |
| Apr 27, 2023 | 1.62 / 1.73 | 6.96B / 7.55B | +5.2% | not recorded | — |
| Feb 02, 2023 | 2.09 / 1.78 | 7.30B / 7.33B | -1.0% | not recorded | — |
| Nov 01, 2022 | 1.98 / 1.92 | 6.94B / 6.89B | -2.0% | not recorded | — |
Reaction = close before the report date to the close of the session after it (report timing is not published by the source; this two-session window contains the reaction either way). Implied moves are recorded live before each report from August 2026 onward — never reconstructed. Earnings data: Financial Modeling Prep.